Lantronix (LTRX) Misses Q3 EPS by 5c ; Offers Guidance

Lantronix (NASDAQ: LTRX) reported Q3 EPS of $0.03, $0.05 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $28.5 million versus the consensus estimate of $34.09 million.

GUIDANCE:

Lantronix sees Q4 2025 EPS of $0.00-$0.02, versus the consensus of $0.03. Lantronix sees Q4 2025 revenue of $26.5-30.5 million, versus the consensus of $30.12 million.

For earnings history and earnings-related data on Lantronix (LTRX) click here.

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77
• Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance